{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:08:27Z","timestamp":1793725707275,"version":"4.6.1"},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Safety"],"published-print":{"date-parts":[[1998]]},"DOI":"10.2165\/00002018-199819010-00002","type":"journal-article","created":{"date-parts":[[2006,1,21]],"date-time":"2006-01-21T10:01:10Z","timestamp":1137837670000},"page":"11-22","source":"Crossref","is-referenced-by-count":74,"title":["Safety of Selegiline (Deprenyl) in the Treatment of Parkinson??s Disease"],"prefix":"10.2165","volume":"19","author":[{"given":"Esa H.","family":"Heinonen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilho","family":"Myllyl??","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","container-title":["Drug Safety"],"original-title":[],"language":"en","deposited":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T14:18:12Z","timestamp":1455027492000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.2165\/00002018-199819010-00002"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[1998]]},"references-count":0,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.2165\/00002018-199819010-00002","relation":{},"ISSN":["0114-5916"],"issn-type":[{"value":"0114-5916","type":"print"}],"subject":[],"published":{"date-parts":[[1998]]}}}